Skip to main content
. 2021 Jul 2;12:581833. doi: 10.3389/fphar.2021.581833

FIGURE 3.

FIGURE 3

Time course of the status of the SARS-CoV-2 Test and End Points. Patients 1 to 15 were in the leflunomide group and patients 16 to 27 were in the standard care group.